The MyD88/CD40 signaling modules, whether inducible or constitutive, significantly improve the survival, persistence, and anti-tumor activity of CAR T-cells by driving the activation of NF-κB and MAPK [35,42,43,62]. Here, NFKB1 is linked to neoplasm.